ANTIBODIES TO EPSTEIN-BARR VIRUS CAPSID ANTIGEN AND EARLY ANTIGEN IN NASOPHARYNGEAL CARCINOMA AND COMPARISON GROUPS
ANTIBODIES TO EPSTEIN-BARR VIRUS CAPSID ANTIGEN AND EARLY ANTIGEN IN NASOPHARYNGEAL CARCINOMA AND COMPARISON GROUPS
复制标题
DOI:
10.1093/oxfordjournals.aje.a112470
复制
发表时间:
1977-01-01
影响因子:
5
通讯作者:
HIRAYAMA, T
中科院分区:
文献类型:
--
作者:
LIN, TM;YANG, CS;HIRAYAMA, T
Antibodies to Epstein-Barr virus capsid antigen (anti-VCA) and early antigen (anti-EA) were measured in 263 patients with nasopharyngeal carcinoma (NPC), 624 age- and sex-matched neighborhood controls, 570 family members of NPC patients and 830 family members of neighborhood controls in Taiwan. The distribution of antibody titers was significantly different between NPC patients and the other 3 groups. More than 55 and 45% of NPC patients had titers of .gtoreq. 1:640 and .gtoreq. 1:80 for anti-VCA and anti-EA, respectively, while < 6.7% and 2.5% of the other 3 groups had such high titers. The geometric means of anti-VCA and anti-EA titers were 1:352 and 1:45, respectively, in NPC patients compared to < 1:77 and 1:12, respectively, in the comparison groups. Anti-VCA and anti-EA titers were significantly correlated. The association of EBV with NPC is discussed.